tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
Advertisement

Summit Therapeutics (SMMT) Similar Stocks

Compare
1,617 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$28.66
$21.28B
165.86%
11 Buy
0 Hold
1 Sell
Strong Buy
BioMarin Pharmaceutical
$57.33
$11.01B
16.98
-35.32%
19 Buy
4 Hold
0 Sell
Strong Buy
Exelixis
$37.72
$10.15B
18.09
39.86%
10 Buy
9 Hold
0 Sell
Moderate Buy
Incyte
$78.39
$15.31B
17.82
28.34%
10 Buy
8 Hold
1 Sell
Moderate Buy
United Therapeutics
$301.50
$13.64B
11.77
-8.71%
8 Buy
4 Hold
0 Sell
Moderate Buy
Genmab
$21.43
$13.26B
10.61
-18.92%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
28.66
17.68
161.02%
BMRN
BioMarin Pharmaceutical
57.33
-31.70
-35.61%
EXEL
Exelixis
37.72
10.79
40.07%
INCY
Incyte
78.39
17.27
28.26%
UTHR
United Therapeutics
301.50
-32.28
-9.67%
GMAB
Genmab
21.43
-5.08
-19.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis